Loading…

Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration

[Display omitted] Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeu...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2022-06, Vol.622, p.121828-121828, Article 121828
Main Authors: Teja Surikutchi, Bhanu, Obenza-Otero, Rebeca, Russo, Emanuele, Zelzer, Mischa, Golán Cancela, Irene, Costoya, José A., Crecente Campo, José, José Alonso, Maria, Marlow, Maria
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783
cites cdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783
container_end_page 121828
container_issue
container_start_page 121828
container_title International journal of pharmaceutics
container_volume 622
creator Teja Surikutchi, Bhanu
Obenza-Otero, Rebeca
Russo, Emanuele
Zelzer, Mischa
Golán Cancela, Irene
Costoya, José A.
Crecente Campo, José
José Alonso, Maria
Marlow, Maria
description [Display omitted] Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.
doi_str_mv 10.1016/j.ijpharm.2022.121828
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2667786710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517322003830</els_id><sourcerecordid>2667786710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</originalsourceid><addsrcrecordid>eNqFkMtu2zAURImgReI4-YQUWnYjhw_x4VUQuG1awEA27ZqgyCuHBkWqpGTAf185drvt6gKDmTuYg9ADwSuCiXjcr_x-eDO5X1FM6YpQoqi6QguiJKtZI8UHtMBMqpoTyW7QbSl7jLGghF2jG8b5muOGLJD5AgcIaeghjlXqKlNFE5M1Q5kC1CEZB656O7qcdhCqLuXK5WlXOQj-APn4rvg4ZjNA9mOKYEJlXO-jL7M4-hTv0MfOhAL3l7tEv759_bn5Xm9fX35snre1bQgda9u11jjTdS1uFHFMtYK5FlSLsRKNawjjqhFcAsOklZTbzlBLueJ2jem8ky3R5_PfIaffE5RR975YCMFESFPRVAgplZAEz1Z-ttqcSsnQ6SH73uSjJlif6Oq9vtDVJ7r6THfOfbpUTG0P7l_qL87Z8HQ2wDz04CHrYj1EC85nsKN2yf-n4g9xdI-n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2667786710</pqid></control><display><type>article</type><title>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</title><source>Elsevier</source><creator>Teja Surikutchi, Bhanu ; Obenza-Otero, Rebeca ; Russo, Emanuele ; Zelzer, Mischa ; Golán Cancela, Irene ; Costoya, José A. ; Crecente Campo, José ; José Alonso, Maria ; Marlow, Maria</creator><creatorcontrib>Teja Surikutchi, Bhanu ; Obenza-Otero, Rebeca ; Russo, Emanuele ; Zelzer, Mischa ; Golán Cancela, Irene ; Costoya, José A. ; Crecente Campo, José ; José Alonso, Maria ; Marlow, Maria</creatorcontrib><description>[Display omitted] Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2022.121828</identifier><identifier>PMID: 35595041</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Intraperitoneal delivery ; Localised drug ; Localised drug delivery ; Nanocapsule ; Ovarian cancer ; PEG hydrogel ; Peritoneal metastases</subject><ispartof>International journal of pharmaceutics, 2022-06, Vol.622, p.121828-121828, Article 121828</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</citedby><cites>FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35595041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teja Surikutchi, Bhanu</creatorcontrib><creatorcontrib>Obenza-Otero, Rebeca</creatorcontrib><creatorcontrib>Russo, Emanuele</creatorcontrib><creatorcontrib>Zelzer, Mischa</creatorcontrib><creatorcontrib>Golán Cancela, Irene</creatorcontrib><creatorcontrib>Costoya, José A.</creatorcontrib><creatorcontrib>Crecente Campo, José</creatorcontrib><creatorcontrib>José Alonso, Maria</creatorcontrib><creatorcontrib>Marlow, Maria</creatorcontrib><title>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.</description><subject>Intraperitoneal delivery</subject><subject>Localised drug</subject><subject>Localised drug delivery</subject><subject>Nanocapsule</subject><subject>Ovarian cancer</subject><subject>PEG hydrogel</subject><subject>Peritoneal metastases</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkMtu2zAURImgReI4-YQUWnYjhw_x4VUQuG1awEA27ZqgyCuHBkWqpGTAf185drvt6gKDmTuYg9ADwSuCiXjcr_x-eDO5X1FM6YpQoqi6QguiJKtZI8UHtMBMqpoTyW7QbSl7jLGghF2jG8b5muOGLJD5AgcIaeghjlXqKlNFE5M1Q5kC1CEZB656O7qcdhCqLuXK5WlXOQj-APn4rvg4ZjNA9mOKYEJlXO-jL7M4-hTv0MfOhAL3l7tEv759_bn5Xm9fX35snre1bQgda9u11jjTdS1uFHFMtYK5FlSLsRKNawjjqhFcAsOklZTbzlBLueJ2jem8ky3R5_PfIaffE5RR975YCMFESFPRVAgplZAEz1Z-ttqcSsnQ6SH73uSjJlif6Oq9vtDVJ7r6THfOfbpUTG0P7l_qL87Z8HQ2wDz04CHrYj1EC85nsKN2yf-n4g9xdI-n</recordid><startdate>20220625</startdate><enddate>20220625</enddate><creator>Teja Surikutchi, Bhanu</creator><creator>Obenza-Otero, Rebeca</creator><creator>Russo, Emanuele</creator><creator>Zelzer, Mischa</creator><creator>Golán Cancela, Irene</creator><creator>Costoya, José A.</creator><creator>Crecente Campo, José</creator><creator>José Alonso, Maria</creator><creator>Marlow, Maria</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220625</creationdate><title>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</title><author>Teja Surikutchi, Bhanu ; Obenza-Otero, Rebeca ; Russo, Emanuele ; Zelzer, Mischa ; Golán Cancela, Irene ; Costoya, José A. ; Crecente Campo, José ; José Alonso, Maria ; Marlow, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Intraperitoneal delivery</topic><topic>Localised drug</topic><topic>Localised drug delivery</topic><topic>Nanocapsule</topic><topic>Ovarian cancer</topic><topic>PEG hydrogel</topic><topic>Peritoneal metastases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teja Surikutchi, Bhanu</creatorcontrib><creatorcontrib>Obenza-Otero, Rebeca</creatorcontrib><creatorcontrib>Russo, Emanuele</creatorcontrib><creatorcontrib>Zelzer, Mischa</creatorcontrib><creatorcontrib>Golán Cancela, Irene</creatorcontrib><creatorcontrib>Costoya, José A.</creatorcontrib><creatorcontrib>Crecente Campo, José</creatorcontrib><creatorcontrib>José Alonso, Maria</creatorcontrib><creatorcontrib>Marlow, Maria</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teja Surikutchi, Bhanu</au><au>Obenza-Otero, Rebeca</au><au>Russo, Emanuele</au><au>Zelzer, Mischa</au><au>Golán Cancela, Irene</au><au>Costoya, José A.</au><au>Crecente Campo, José</au><au>José Alonso, Maria</au><au>Marlow, Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2022-06-25</date><risdate>2022</risdate><volume>622</volume><spage>121828</spage><epage>121828</epage><pages>121828-121828</pages><artnum>121828</artnum><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] Intraperitoneal (IP) drug delivery of chemotherapeutic agents, administered through hyperthermal intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosolized chemotherapy (PIPAC), is effective for the treatment of peritoneal malignancies. However, these therapeutic interventions are cumbersome in terms of surgical practice and are often associated with the formation of peritoneal adhesions, due to the catheters inserted into the peritoneal cavity during these procedures. Hence, there is a need for the development of drug delivery systems that can be administered into the peritoneal cavity. In this study, we have developed a nanocapsule (NCs)-loaded hydrogel for drug delivery in the peritoneal cavity. The hydrogel has been developed using poly(ethylene glycol) (PEG) and thiol-maleimide chemistry. NCs-loaded hydrogels were characterized by rheology and their resistance to dilution and drug release were determined in vitro. Using IVIS® to measure individual organ and recovered gel fluorescence intensity, an in vivo imaging study was performed and demonstrated that NCs incorporated in the PEG gel were retained in the IP cavity for 24 h after IP administration. NCs-loaded PEG gels could find potential applications as biodegradable, drug delivery systems that could be implanted in the IP cavity, for example at a the tumour resection site to prevent recurrence of microscopic tumours.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>35595041</pmid><doi>10.1016/j.ijpharm.2022.121828</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2022-06, Vol.622, p.121828-121828, Article 121828
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2667786710
source Elsevier
subjects Intraperitoneal delivery
Localised drug
Localised drug delivery
Nanocapsule
Ovarian cancer
PEG hydrogel
Peritoneal metastases
title Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A02%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20nanocapsule-loaded%20hydrogel%20for%20drug%20delivery%20for%20intraperitoneal%20administration&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Teja%20Surikutchi,%20Bhanu&rft.date=2022-06-25&rft.volume=622&rft.spage=121828&rft.epage=121828&rft.pages=121828-121828&rft.artnum=121828&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2022.121828&rft_dat=%3Cproquest_cross%3E2667786710%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-cfbcadaffb0481d38b63dbe8b00864d413584657e301b725cfa2c2585c9023783%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2667786710&rft_id=info:pmid/35595041&rfr_iscdi=true